0001838748-21-000001.txt : 20210105 0001838748-21-000001.hdr.sgml : 20210105 20210105114604 ACCESSION NUMBER: 0001838748-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210105 DATE AS OF CHANGE: 20210105 EFFECTIVENESS DATE: 20210105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Endogena Therapeutics, Inc. CENTRAL INDEX KEY: 0001838748 IRS NUMBER: 813692564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-385229 FILM NUMBER: 21504419 BUSINESS ADDRESS: STREET 1: 111 PINE STREET STREET 2: SUITE 1410 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 415-433-2262 MAIL ADDRESS: STREET 1: 111 PINE STREET STREET 2: SUITE 1410 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 D 1 primary_doc.xml X0708 D LIVE 0001838748 Endogena Therapeutics, Inc. 111 PINE STREET SUITE 1410 SAN FRANCISCO CA CALIFORNIA 94111 415-433-2262 DELAWARE None None Corporation true 2016 Matthias Steger 111 Pine Street Suite 1410 San Francisco CA CALIFORNIA 94111 Executive Officer Director Dirk Harbecke 111 Pine Street Suite 1410 San Francisco CA CALIFORNIA 94111 Director Elona Baum 111 Pine Street Suite 1410 San Francisco CA CALIFORNIA 94111 Director Daniel Zabrowski 111 Pine Street Suite 1410 San Francisco CA CALIFORNIA 94111 Director Other Decline to Disclose 06b false 2020-12-21 false true false 1 7999999 7999924 75 false 13 0 0 0 false Endogena Therapeutics, Inc. /s/ Matthias Steger Matthias Steger President 2021-01-05